Axon price target raised to $300 from $237 at Credit Suisse

Credit Suisse analyst Sami Badri raised the firm’s price target on Axon to $300 from $237 and keeps an Outperform rating on the shares ahead of the Q1 results. Axon has raised prices on core products by 10%+, signaling strong pricing power due to high product stickiness and robust demand, the analyst tells investors in a research note.